Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ/Minimally Invasive Adenocarcinoma (AIS/MIA)
暂无分享,去创建一个
H. Morgenstern | L. Le Marchand | D. Christiani | Shen-Chih Chang | P. Boffetta | Ping Yang | M. Neri | R. Hung | J. Wampfler | A. Schwartz | D. Ugolini | D. Xie | M. Cote | Y. Lee | C. Kim | Zuo‐Feng Zhang
[1] H. Morgenstern,et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO) , 2014, International journal of cancer.
[2] Sander Greenland,et al. Maximum likelihood, profile likelihood, and penalized likelihood: a primer. , 2014, American journal of epidemiology.
[3] Sander Greenland,et al. Bayesian regression in SAS software. , 2013, International journal of epidemiology.
[4] P. Bracci,et al. Cigarette Smoking Associated With Lung Adenocarcinoma In Situ in a Large Case-Control Study (SFBALCS) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] Masahiro Tsuboi,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[6] H. Morgenstern,et al. Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case–control studies in the International Lung Cancer Consortium (ILCCO) , 2010, Cancer Causes & Control.
[7] Ugolini Donatella,et al. The CREST Biorepository: A Tool for Molecular Epidemiology and Translational Studies on Malignant Mesothelioma, Lung Cancer, and Other Respiratory Tract Diseases , 2008, Cancer Epidemiology Biomarkers & Prevention.
[8] W. Bamlet,et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. , 2008, Archives of internal medicine.
[9] A. Schwartz,et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] D. Arenberg. Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.
[11] R. Rosell,et al. Bronchioloalveolar carcinoma: a review. , 2006, Clinical lung cancer.
[12] H. Morgenstern,et al. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus , 2006, International journal of cancer.
[13] S. Land,et al. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. , 2004, Carcinogenesis.
[14] R. Govindan,et al. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. , 2004, Lung cancer.
[15] T. Sellers,et al. Environmental tobacco smoke exposure in women with lung cancer. , 2004, Lung cancer.
[16] P. Boffetta. Involuntary smoking and lung cancer. , 2002, Scandinavian journal of work, environment & health.
[17] K. Sugimachi,et al. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] D. Christiani,et al. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] L. Kolonel,et al. Intake of Flavonoids and Lung Cancer. , 2000, Journal of the National Cancer Institute.
[20] N J Wald,et al. The accumulated evidence on lung cancer and environmental tobacco smoke , 1997, BMJ.
[21] G. Swanson,et al. Familial risk of lung cancer among nonsmokers and their relatives. , 1996, American journal of epidemiology.
[22] S. Barsky,et al. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features , 1994, Cancer.
[23] L. Pickle,et al. Epidemiology of bronchioloalveolar carcinoma. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[24] E. Wynder,et al. Cigarette smoking and lung cancer cell types , 1991, Cancer.
[25] S. Piantadosi,et al. Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung--The Lung Cancer Study Group experience. , 1989, Annals of surgery.
[26] G. Friedman,et al. Predictors of lung cancer: noteworthy cell type differences. , 2013, The Permanente journal.
[27] L. Tanoue. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2012 .
[28] B. Parodi,et al. The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. , 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[29] S. Land,et al. GSTM 1 , GSTT 1 and GSTP 1 polymorphisms , environmental tobacco smoke exposure and risk of lung cancer among never smokers : a population-based study , 2005 .